{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:20:08Z","timestamp":1761128408698},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1994,9,1]],"date-time":"1994-09-01T00:00:00Z","timestamp":778377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1994,9]]},"DOI":"10.1007\/bf02276052","type":"journal-article","created":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T09:09:49Z","timestamp":1134119389000},"page":"701-710","source":"Crossref","is-referenced-by-count":23,"title":["Use of teicoplanin in community medicine"],"prefix":"10.1007","volume":"13","author":[{"given":"A. P. R.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Gr\u00fcneberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Supplement 2","key":"BF02276052_CR1","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1093\/clinids\/13.Supplement_2.S184","volume":"13","author":"AD Tice","year":"1991","unstructured":"Tice AD: An office model of outpatient parenteral antibiotic therapy. Reviews of Infectious Diseases 1991, 13, Supplement 2: S184-S188.","journal-title":"Reviews of Infectious Diseases"},{"key":"BF02276052_CR2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF02026127","volume":"13","author":"A Voss","year":"1994","unstructured":"Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I: Methicillin-resistantStaphylococcus aureus in Europe. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 50\u201355.","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF02276052_CR3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jama.1982.03330030042023","volume":"248","author":"DM Poretz","year":"1982","unstructured":"Poretz DM, Eron LJ, Goldenberg RI, Gilbert AF, Rising J, Sparks S, Horn CE: Intravenous antibiotic therapy in an outpatient setting. Journal of the American Medical Association 1982, 248: 336\u2013339.","journal-title":"Journal of the American Medical Association"},{"key":"BF02276052_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.7326\/0003-4819-99-3-388","volume":"99","author":"SJ Rehm","year":"1983","unstructured":"Rehm SJ, Weinstein AJ: Home intravenous antibiotic therapy: a team approach. Annals of Internal Medicine 1983, 99: 388\u2013392.","journal-title":"Annals of Internal Medicine"},{"issue":"Supplement 4C","key":"BF02276052_CR5","first-page":"77","volume":"77","author":"DM Poretz","year":"1984","unstructured":"Poretz DM, Woolard D, Eron LJ, Goldenberg RI, Rising J, Sparks S: Outpatient use of ceftriaxone: a cost-benefit analysis. American Journal of Medicine 1984, 77, Supplement 4C: 77\u201383.","journal-title":"American Journal of Medicine"},{"key":"BF02276052_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0002-9343(89)80155-X","volume":"87","author":"W Balinsky","year":"1989","unstructured":"Balinsky W, Nesbitt S: Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature. American Journal of Medicine 1989, 87: 301\u2013305.","journal-title":"American Journal of Medicine"},{"key":"BF02276052_CR7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/jac\/31.6.985","volume":"31","author":"GA Halls","year":"1993","unstructured":"Halls GA: The management of infections and anti-biotic therapy: a European survey. Journal of Antimicrobial Chemotherapy 1993, 31: 985\u20131000.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/clinids\/14.6.1173","volume":"14","author":"RC Moellering","year":"1992","unstructured":"Moellering RC: Emergence ofEnterococcus as a significant pathogen. Clinical Infectious Diseases 1992, 14: 1173\u20131178.","journal-title":"Clinical Infectious Diseases"},{"key":"BF02276052_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/clinids\/15.1.95","volume":"15","author":"P Geslin","year":"1992","unstructured":"Geslin P, Buu-Hoi A, Fr\u00e9maux A, Acar JF: Antimicrobial resistance inStreptococcus pneumoniae: an epidemiological survey in France 1970\u20131990. Clinical Infectious Diseases 1992, 15: 95\u201398.","journal-title":"Clinical Infectious Diseases"},{"issue":"Supplement B","key":"BF02276052_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0195-6701(85)80085-2","volume":"6","author":"GAJ Ayliffe","year":"1985","unstructured":"Ayliffe GAJ, Lilly HA: Cross-infection and its prevention. Journal of Hospital Infection 1985, 6, Supplement B: 47\u201357.","journal-title":"Journal of Hospital Infection"},{"key":"BF02276052_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2165\/00003088-199018030-00002","volume":"18","author":"M Rowland","year":"1990","unstructured":"Rowland M: Clinical pharmacokinetics of teicoplanin. Clinical Pharmacokinetics 1990, 18: 184\u2013209.","journal-title":"Clinical Pharmacokinetics"},{"key":"BF02276052_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/bdd.2510130307","volume":"13","author":"GA Thompson","year":"1992","unstructured":"Thompson GA, Smithers JA, Kenny MT, Dulworth JK, Kulmala HK, Yuh L, Lewis EW, Antony KK: Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers. Biopharmaceutics and Drug Disposition 1992, 13: 213\u2013220.","journal-title":"Biopharmaceutics and Drug Disposition"},{"issue":"Supplement A","key":"BF02276052_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jac\/21.suppl_A.61","volume":"21","author":"P Lewis","year":"1988","unstructured":"Lewis P, Garaud JJ, Parenti F: A multicentre open clinical trial of teicoplanin in infections caused by gram-positive bacteria. Journal of Antimicrobial Chemotherapy 1988, 21, Supplement A: 61\u201367.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR14","first-page":"63","volume":"3","author":"S Amaducci","year":"1992","unstructured":"Amaducci S, Barbieri D, Cogo R, Dardes N, Fracchia C, Guffanti E, Pela R, Rampulla C, Sanguinetti CM, Zanon P, Grassi C: Valutazione comparativa di trattamenti antibiotici empirici in pazienti insufficienza respiratoria cronica con riacutizzazione infettiva bronchiale. Antibioticoterapia per la Pratica 1992, 3: 63\u201370.","journal-title":"Antibioticoterapia per la Pratica"},{"key":"BF02276052_CR15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/jac\/23.6.869","volume":"23","author":"N Derbyshire","year":"1989","unstructured":"Derbyshire N, Webb DB, Roberts D, Glew D, Williams JD: Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function. Journal of Antimicrobial Chemotherapy 1989, 23: 869\u2013876.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.35.4.696","volume":"35","author":"MJ Rybak","year":"1991","unstructured":"Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, Kenny MT, Yuh L: Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrobial Agents and Chemotherapy 1991, 35: 696\u2013700.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement B","key":"BF02276052_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/27.suppl_B.69","volume":"27","author":"PG Davey","year":"1991","unstructured":"Davey PG, Williams AH: A review of the safety profile of teicoplanin. Journal of Antimicrobial Chemotherapy 1991, 27, Supplement B: 69\u201373.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR18","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1128\/AAC.35.11.2246","volume":"35","author":"A Kureishi","year":"1991","unstructured":"Kureishi A, Jewesson PJ, Rubinger M, Cole CD, Reece DE, Phillips GL, Smith JA, Chow AW: Doubleblind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity. Antimicrobial Agents and Chemotherapy 1991, 35: 2246\u20132252.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02276052_CR19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/23.5.810","volume":"23","author":"SR Smith","year":"1989","unstructured":"Smith SR, Cheesbrough JM, Makris M, Davies JM: Teicoplanin administration in patients experiencing reactions to vancomycin. Journal of Antimicrobial Chemotherapy 1989, 23: 810\u2013812.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR20","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jac\/31.5.755","volume":"31","author":"E Presterl","year":"1993","unstructured":"Presterl E, Graninger W, Georgopoulos A: The efficacy of teicoplanin in the treatment of endocarditis caused by gram-positive bacteria. Journal of Antimicrobial Chemotherapy 1993, 31: 755\u2013766.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR21","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/AAC.33.6.871","volume":"33","author":"C Leport","year":"1989","unstructured":"Leport C, Perronne C, Massip P, Canton P, Leclerq P, Bernard E, Lutun P, Garaud JJ, Vilde J: Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients. Antimicrobial Agents and Chemotherapy 1989, 33: 871\u2013876.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02276052_CR22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.33.8.1329","volume":"33","author":"P Martino","year":"1989","unstructured":"Martino P, Venditti M, Micozzi A, Brandimarte C, Gentile G, Santini C, Serra P: Teicoplanin in the treatment of gram-positive bacterial endocarditis. Antimicrobial Agents and Chemotherapy 1989, 33: 1329\u20131334.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02276052_CR23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1128\/AAC.35.1.79","volume":"35","author":"DN Gilbert","year":"1991","unstructured":"Gilbert DN, Wood CA, Kimbrough RC, The Infectious Disease Consortium of Oregon: Failure of treatment with teicoplanin at 6 milligrams\/kilogram\/day in patients withStaphylococcus aureus intravascular infection. Antimicrobial Agents and Chemotherapy 1991, 35: 79\u201387.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02276052_CR24","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/jac\/32.6.792","volume":"32","author":"APR Wilson","year":"1993","unstructured":"Wilson APR, Gr\u00fcneberg RN, Neu H: Dosage recommendations for teicoplanin. Journal of Antimicrobial Chemotherapy 1993, 32: 792\u2013796.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02276052_CR25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","volume":"34","author":"PM Small","year":"1990","unstructured":"Small PM, Chambers HF: Vancomycin forStaphylococcus aureus endocarditis in intravenous drug users. Antimicrobial Agents and Chemotherapy 1990, 34: 1227\u20131231.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02276052_CR26","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","volume":"115","author":"DP Levine","year":"1991","unstructured":"Levine DP, Fromm BS, Reddy BR: Slow response to vancomycin or vancomycin plus rifampicin in methicillin-resistantStaphylococcus aureus endocarditis. Annals of Internal Medicine 1991, 115: 674\u2013680.","journal-title":"Annals of Internal Medicine"},{"key":"BF02276052_CR27","first-page":"9","volume":"Supplement 567","author":"JL Frock Le","year":"1992","unstructured":"Le Frock JL, Ristuccia AM, Ristuccia PA, Quenzer RW, Haggerty PG, Allen JE, Lettau LA, Schwartz R, Appleby D: Teicoplanin in the treatment of bone and joint infections. European Journal of Surgery 1992, Supplement 567, 9\u201313.","journal-title":"European Journal of Surgery"},{"issue":"Supplement 1","key":"BF02276052_CR28","first-page":"41","volume":"28","author":"PC Craven","year":"1993","unstructured":"Craven PC: Treating bone and joint infections with teicoplanin: hospitalization vs outpatient cost issues. Hospital Formulary 1993, 28, Supplement 1: 41\u201345.","journal-title":"Hospital Formulary"},{"issue":"Supplement 2","key":"BF02276052_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.1990.tb07934.x","volume":"76","author":"P Cony-Makhoul","year":"1990","unstructured":"Cony-Makhoul P, Brossard G, Marit G, Pellegrin JL, Texier-Maugein J, Reiffers J: A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients. British Journal of Haematology 1990, 76, Supplement 2: 35\u201340.","journal-title":"British Journal of Haematology"},{"key":"BF02276052_CR30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.33.8.1193","volume":"33","author":"SR Smith","year":"1989","unstructured":"Smith SR, Cheesbrough J, Spearing R, Davies JM: Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters. Antimicrobial Agents and Chemotherapy 1989, 33: 1193\u20137.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02276052_CR31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/AAC.35.3.451","volume":"35","author":"P Auwera Van der","year":"1991","unstructured":"Van der Auwera P, Aoun M, Meunier F: Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts. Antimicrobial Agents and Chemotherapy 1991, 35, 451\u2013457.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Supplement 54","key":"BF02276052_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0609.1993.tb01900.x","volume":"51","author":"LM Ball","year":"1993","unstructured":"Ball LM, Siddal S, van Saenen H: Teicoplanin in home therapy of the terminally ill child. European Journal of Haematology 1993, 51, Supplement 54: 14\u201317.","journal-title":"European Journal of Haematology"},{"key":"BF02276052_CR33","first-page":"459.1","volume-title":"Recent advances in chemotherapy","author":"W Holloway","year":"1990","unstructured":"Holloway W, Bacon A, Reinhardt J: Teicoplanin in skin and soft tissue infections. In: Rubinstein E, Adam D (ed): Recent advances in chemotherapy. Proceedings of the 16th International Congress of Chemotherapy. Lewin-Epstein, Jerusalem, 1990, 2: 459.1\u2013459.2."},{"key":"BF02276052_CR34","first-page":"27","volume":"Supplement 567","author":"E Rubinstein","year":"1992","unstructured":"Rubinstein E: Teicoplanin \u2014 domiciliary use in surgical interventions. European Journal of Surgery 1992, Supplement 567: 27\u201329.","journal-title":"European Journal of Surgery"},{"key":"BF02276052_CR35","first-page":"51","volume":"28","author":"CH Nightingale","year":"1993","unstructured":"Nightingale CH: Impact of nosocomial infections on hospital costs. Hospital Formulary 1993, 28: 51\u201354.","journal-title":"Hospital Formulary"},{"issue":"Supplement 1","key":"BF02276052_CR36","first-page":"S17","volume":"12","author":"R Dagan","year":"1993","unstructured":"Dagan R, Einhorn M, Howard CB, Williams AH: Outpatient and inpatient teicoplanin treatment for serious infections in children. Pediatric Infectious Disease Journal 1993, 12, Supplement 1: S17-S20.","journal-title":"Pediatric Infectious Disease Journal"},{"key":"BF02276052_CR37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.2042-7174.1991.tb00543.x","volume":"1","author":"WM Mawhinney","year":"1991","unstructured":"Mawhinney WM, Adair CG, Gorman SP, McClurg B: Long-term stability of teicoplanin in dialysis fluid: implications for the home treatment of CAPD peritonitis. International Journal of Pharmacy Practice 1991, 1: 90\u201393.","journal-title":"International Journal of Pharmacy Practice"},{"issue":"Supplement 1","key":"BF02276052_CR38","first-page":"1","volume":"1","author":"W Al-Wali","year":"1992","unstructured":"Al-Wali W, Baillod RA, Brumfitt W, Hamilton-Miller JMT: Teicoplanin in the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis: a comparative trial against vancomycin. International Journal of Antimicrobial Agents 1992, 1, Supplement 1: 1\u20136.","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"Supplement 1","key":"BF02276052_CR39","first-page":"7","volume":"1","author":"MCJ Wale","year":"1992","unstructured":"Wale MCJ, Finch RG, Morgan AG, Burden RP, Holliday A: A prospective randomised trial of teicoplanin plus aztreonam versus cefuroxime in CAPD peritonitis. International Journal of Antimicrobial Agents 1992, 1, Supplement 1: 7\u201313.","journal-title":"International Journal of Antimicrobial Agents"},{"key":"BF02276052_CR40","unstructured":"Joint Formulary Committee: British National Formulary. British Medical Association and Royal Pharmaceutical Society of Great Britain, London, September 1993, Number 26, p. 199."},{"key":"BF02276052_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/20.1.85","volume":"20","author":"DC Shanson","year":"1987","unstructured":"Shanson DC, Shehata A, Tadayon M, Harris M: Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients. Journal of Antimicrobial Chemotherapy 1987, 20: 85\u201393.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"Supplement 1","key":"BF02276052_CR42","first-page":"9","volume":"3","author":"PG Davey","year":"1993","unstructured":"Davey PG: The economics of hospital antibiotic use in the changing world. British Journal of Intensive Care 1993, 3, Supplement 1: 9\u201312.","journal-title":"British Journal of Intensive Care"},{"key":"BF02276052_CR43","first-page":"104","volume":"77","author":"DJ Tanner","year":"1984","unstructured":"Tanner DJ, Nazarian MQ: Cost containment associated with decreased parenteral antibiotic administration frequencies. American Journal of Medicine 1984, 77: 104\u2013111.","journal-title":"American Journal of Medicine"},{"key":"BF02276052_CR44","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/archinte.1983.00350100030009","volume":"143","author":"JD Baumgartner","year":"1983","unstructured":"Baumgartner JD, Glauser MP: Single daily dose treatment of severe refractory infections with ceftriaxone. Annals of Internal Medicine 1983, 143: 1868\u20131873.","journal-title":"Annals of Internal Medicine"},{"key":"BF02276052_CR45","first-page":"55","volume":"28","author":"RN Gr\u00fcneberg","year":"1993","unstructured":"Gr\u00fcneberg RN: The true cost of monitoring antibiotic levels. Hospital Formulary 1993, 28: 55\u20138.","journal-title":"Hospital Formulary"},{"issue":"Supplement A","key":"BF02276052_CR46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0195-6701(91)90009-W","volume":"18","author":"RP Wenzel","year":"1991","unstructured":"Wenzel RP, Pfaller MA: Feasible and desirable future targets for reducing the costs of hospital infections. Journal of Hospital Infection 1991, 18, Supplement A: 94\u201398.","journal-title":"Journal of Hospital Infection"},{"issue":"Supplement A","key":"BF02276052_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0195-6701(91)90007-U","volume":"18","author":"PG Davey","year":"1991","unstructured":"Davey PG, Hernanz C, Lynch W, Malek M, Byrne D: Human and non-financial costs of hospital acquired infection. Journal of Hospital Infection 1991, 18, Supplement A: 79\u201384.","journal-title":"Journal of Hospital Infection"},{"key":"BF02276052_CR48","first-page":"59","volume":"28","author":"J Korin","year":"1993","unstructured":"Korin J: Cost implications of malpractice and adverse events. Hospital Formulary 1993, 28: 59\u201361.","journal-title":"Hospital Formulary"},{"key":"BF02276052_CR49","first-page":"46","volume":"28","author":"E Rubinstein","year":"1993","unstructured":"Rubinstein E: Cost implications of home care on serious infections. Hospital Formulary 1993, 28: 46\u201350.","journal-title":"Hospital Formulary"},{"key":"BF02276052_CR50","first-page":"20","volume":"28","author":"GS Schaison","year":"1993","unstructured":"Schaison GS: Cost effectiveness of teicoplanin and ceftriaxone: a once daily antibiotic regimen. Hospital Formulary 1993, 28: 20\u201322.","journal-title":"Hospital Formulary"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02276052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02276052\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02276052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:29:21Z","timestamp":1706804961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02276052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1994,9]]}},"alternative-id":["BF02276052"],"URL":"https:\/\/doi.org\/10.1007\/bf02276052","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,9]]}}}